Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 80 resultados

AIRCARE: AI augmented Robotics for CAncer point of caRE Cancer in the Upper Aerodigestive Tract (UADT) is still among the leading cancer types worldwide, with both incidence rate and mortality rat...
2024-06-28 - 2028-06-30 | Financiado

TB-QUEST: Questioning the Epidemiology of Subclinical Tuberculosis HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: ERC-2023-STG Tuberculosis (TB) remains a major cause of morbidity and mortality around the world. The majority of TB control policies rely on the binary...
2024-04-18 - 2029-04-30 | Financiado

INTENSE-TBM-2: Intensified tuberculosis treatment to reduce the high mortality of tuberculous meningitis in HIV-inf... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 Tuberculosis (TB) remains a global health problem. The most lethal and disabling form of TB is tuberculous meningitis (TBM), with an estimat...
2024-03-04 - 2026-12-31 | Financiado

DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherap...
2023-12-11 - 2028-11-30 | Financiado

EDiHTA: The first European Digital Health Technology Assessment framework co-created by all stakeholders alo... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 Digital health technologies (DHTs) are expected to improve both the quality and delivery of healthcare services for European societies while...
2023-11-28 - 2027-12-31 | Financiado

LIVERAIM: A Biomarker Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Thera... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Liver cirrhosis and liver cancer are common and responsible for high morbidity, impaired quality of life, major costs for healthcare systems...
2023-11-27 - 2030-02-28 | Financiado

TOUCH: Towards the next generatiOn of excellent yoUng doctoral researchers on mental health by developing a... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-COFUND-01 TOUCH (Towards the next generatiOn of excellent yoUng doctoral researchers on mental health by developing an intersectoral & transdisciplina...
2023-09-21 - 2029-01-31 | Financiado

FIBROTARGET: Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD). Current IBD therapies...
2023-04-24 - 2028-03-31 | Financiado

IMPORTANT: IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 Current evidence from both randomized trials and real-world evidence studies suggests that older breast cancer patients derive clinical bene...
2023-04-24 - 2028-04-30 | Financiado

NEMESIS: NEurological MEchanismS of Injury, and Sleep-like cellular dynamics HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: ERC-2022-SYG Focal brain disorders, including stroke, trauma, and epilepsy, are the main causes of disability and loss of productivity in the world, and...
2023-02-28 - 2029-09-30 | Financiado

MELCAYA: Novel health care strategies for melanoma in children adolescents and young adults HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 "In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized...
2022-12-01 - 2026-11-30 | Financiado

halt-RONIN: Discovering chronic inflammation biomarkers that define key stages in the Healthy to NASH non alcoh... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-02 Non-alcoholic fatty liver disease (NAFLD) is a multifactorial chronic inflammatory disease that is prevalent in 1 of 4 individuals with a si...
2022-11-22 - 2026-11-30 | Financiado

END-VOC: ENDING COVID 19 VARIANTS OF CONCERN THROUGH COHORT STUDIES: END-VOC HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The END-VOC consortium will support the European and global response to the COVID-19 pandemic and Variants of Concern (VOC) through well cha...
2022-08-17 - 2025-04-30 | Financiado

STEPUPIORS: TWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENT... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-WIDERA-2021-ACCESS-03 "Neoadjuvant chemoradiotherapy (CRT) is the gold standard in locally advanced rectal cancer (LARC), but the response is not uniform among pa...
2022-07-14 - 2025-09-30 | Financiado

SoftEnable: Towards Soft Fixture-Based Manipulation Primitives Enabling Safe Robotic Manipulation in Hazardous H... HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-CL4-2021-DIGITAL-EMERGING-01 Fresh food processing is a labour intensive task requiring workers to operate in hazardous environments such as cold rooms while handling de...
2022-06-23 - 2026-09-30 | Financiado

RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 HOSPITAL CLINIC DE BARCELONA participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado

RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education HOSPITAL CLINIC DE BARCELONA participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado

HIPPOCRATES: Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States HOSPITAL CLINIC DE BARCELONA participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Psoriatic Arthritis (PsA) is a clinically heterogeneous disease associated with diminished quality of life. Early diagnosis is challenging a...
2021-06-29 - 2026-06-30 | Financiado

PSY-PGx: A New Intervention for Implementation of Pharmacogenetics in Psychiatry HOSPITAL CLINIC DE BARCELONA participó en un H2020: H2020-SC1-BHC-2018-2020 Due to the chronic relapsing nature of mental disorders and increased life expectancy, the societal burden of these non-communicable disease...
2021-02-01 - 2026-02-28 | Financiado

iToBoS: Intelligent Total Body Scanner for Early Detection of Melanoma HOSPITAL CLINIC DE BARCELONA participó en un H2020: H2020-SC1-BHC-2018-2020 Melanoma is one of the most aggressive cancers that can be discovered at an early stage, and it is responsible for 60% of lethal skin neopla...
2021-01-29 - 2025-03-31 | Financiado